Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia
Introduction: Today, recommendations about initial Response Evaluation Criteria in Solid Tumor (RECIST) and its frequency still vary, while early diagnosis of progression affects patient’s prognosis and subsequent treatment options.
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2023-03-01
|
| Series: | Romanian Journal of Internal Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/rjim-2022-0020 |
| _version_ | 1797848544692928512 |
|---|---|
| author | Widiasari Ni Putu Ayu Rai Ida Bagus Ngurah Dwi Kusumawardani Ida Ayu Jasminarti Sajinadiyasa I Gede Ketut Candrawati Ni Wayan Arisanti Ni Luh Putu Eka |
| author_facet | Widiasari Ni Putu Ayu Rai Ida Bagus Ngurah Dwi Kusumawardani Ida Ayu Jasminarti Sajinadiyasa I Gede Ketut Candrawati Ni Wayan Arisanti Ni Luh Putu Eka |
| author_sort | Widiasari Ni Putu Ayu |
| collection | DOAJ |
| description | Introduction: Today, recommendations about initial Response Evaluation Criteria in Solid Tumor (RECIST) and its frequency still vary, while early diagnosis of progression affects patient’s prognosis and subsequent treatment options. |
| first_indexed | 2024-04-09T18:29:14Z |
| format | Article |
| id | doaj.art-ef364c868a434e88b2e1034ac418cec3 |
| institution | Directory Open Access Journal |
| issn | 2501-062X |
| language | English |
| last_indexed | 2024-04-09T18:29:14Z |
| publishDate | 2023-03-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Romanian Journal of Internal Medicine |
| spelling | doaj.art-ef364c868a434e88b2e1034ac418cec32023-04-11T17:35:39ZengSciendoRomanian Journal of Internal Medicine2501-062X2023-03-01611637110.2478/rjim-2022-0020Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, IndonesiaWidiasari Ni Putu Ayu0Rai Ida Bagus Ngurah1Dwi Kusumawardani Ida Ayu Jasminarti2Sajinadiyasa I Gede Ketut3Candrawati Ni Wayan4Arisanti Ni Luh Putu Eka5Pulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, IndonesiaPulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, IndonesiaPulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, IndonesiaPulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, IndonesiaPulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, IndonesiaPulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, IndonesiaIntroduction: Today, recommendations about initial Response Evaluation Criteria in Solid Tumor (RECIST) and its frequency still vary, while early diagnosis of progression affects patient’s prognosis and subsequent treatment options.https://doi.org/10.2478/rjim-2022-0020adenocarcinomaegfrneutrophil-to-lymphocyte ratiotyrosine kinase inhibitorprogression free survival |
| spellingShingle | Widiasari Ni Putu Ayu Rai Ida Bagus Ngurah Dwi Kusumawardani Ida Ayu Jasminarti Sajinadiyasa I Gede Ketut Candrawati Ni Wayan Arisanti Ni Luh Putu Eka Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia Romanian Journal of Internal Medicine adenocarcinoma egfr neutrophil-to-lymphocyte ratio tyrosine kinase inhibitor progression free survival |
| title | Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia |
| title_full | Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia |
| title_fullStr | Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia |
| title_full_unstemmed | Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia |
| title_short | Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia |
| title_sort | pre treatment neutrophil to lymphocyte ratio significantly affects progression free survival in positive egfr mutation advanced lung adenocarcinoma with egfr tki treatment in bali indonesia |
| topic | adenocarcinoma egfr neutrophil-to-lymphocyte ratio tyrosine kinase inhibitor progression free survival |
| url | https://doi.org/10.2478/rjim-2022-0020 |
| work_keys_str_mv | AT widiasariniputuayu pretreatmentneutrophiltolymphocyteratiosignificantlyaffectsprogressionfreesurvivalinpositiveegfrmutationadvancedlungadenocarcinomawithegfrtkitreatmentinbaliindonesia AT raiidabagusngurah pretreatmentneutrophiltolymphocyteratiosignificantlyaffectsprogressionfreesurvivalinpositiveegfrmutationadvancedlungadenocarcinomawithegfrtkitreatmentinbaliindonesia AT dwikusumawardaniidaayujasminarti pretreatmentneutrophiltolymphocyteratiosignificantlyaffectsprogressionfreesurvivalinpositiveegfrmutationadvancedlungadenocarcinomawithegfrtkitreatmentinbaliindonesia AT sajinadiyasaigedeketut pretreatmentneutrophiltolymphocyteratiosignificantlyaffectsprogressionfreesurvivalinpositiveegfrmutationadvancedlungadenocarcinomawithegfrtkitreatmentinbaliindonesia AT candrawatiniwayan pretreatmentneutrophiltolymphocyteratiosignificantlyaffectsprogressionfreesurvivalinpositiveegfrmutationadvancedlungadenocarcinomawithegfrtkitreatmentinbaliindonesia AT arisantiniluhputueka pretreatmentneutrophiltolymphocyteratiosignificantlyaffectsprogressionfreesurvivalinpositiveegfrmutationadvancedlungadenocarcinomawithegfrtkitreatmentinbaliindonesia |